India’s Biologics Market To Hit $12 Billion By 2025 – Reports

Biologics and Biosimilars Industry in India is Growing Faster Than
Ever. India, now the emerging hub for biosimilars and biologics,
always possessed the skills to work on small molecules required to
make generic drugs. Still, they lacked the skills and environment to
develop reverse-engineered versions of biotech drugs. However, the
launch of 123 biosimilars, in […]

The post India's Biologics Market To Hit $12 Billion By 2025 – Reports
appeared first on BioTecNika .

https://www.biotecnika.org/2019/12/biologics-and-biosimilars-industry-in-india-is-growing-faster-than-ever/

Biotech News

Comments

Popular posts from this blog

Clinical Database Management Professional Vacancy @ Teva

Pharma Production Executive Post Vacancy @ Intas

Biotecnika Times – Newsletter 28.02.2020 – DST Women Scientist WOS B, DBT-IOC Recruitment